Trailing-twelve-month (TTM) revenue is $1.81 Billion with a year-over-year growth of +16.28%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $441,284,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-28 |
| Q4 FY2025Period ended 2025-12-31 | $441,963,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-24 |
| Q1 FY2026Period ended 2026-03-31 | $451,767,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $475,042,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-28 |
| TTM revenue | $1,810,056,000 |
Current P/S: $2,502,022,326 market capitalization ÷ $1,810,056,000 TTM revenue = 1.38x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $475.04M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:12:16.615Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Business Advisory | $14M | N/A | N/A | N/A | N/A | N/A |
| Commercial | N/A | N/A |
$1.81B
$1.81 Billion
+16.28%
vs. $1.56B a year ago (TTM)
+16.68%
5 Year compound annual growth rate
1 Year
+16.28%
3 Year
+12.72%
5 Year
+16.68%
10 Year
+9.58%
15 Year
+7.10%
20 Year
+10.15%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.70B | +$213.06M | +14.34% |
| 2024 | $1.49B | +$124.03M | +9.11% |
| 2023 | $1.36B | +$229.60M | +20.27% |
| 2022 | $1.13B | +$226.81M | +25.04% |
| 2021 | $905.64M | +$61.51M | +7.29% |
| 2020 |
TTM Growth
+16.28%
3-Year CAGR
+12.72%
5-Year CAGR
+16.68%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:12:16.615Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $238M |
| $258M |
| $261M |
| $331M |
| Education | $32M | $39M | $360M | $430M | $484M | $510M |
|---|
| Healthcare | $99M | $48M | $535M | $674M | $777M | $858M |
|---|
| $844.13M |
| ($32.63M) |
| (3.72%) |
| 2019 | $876.76M | +$81.63M | +10.27% |
| 2018 | $795.13M | +$62.55M | +8.54% |
| 2017 | $732.57M | +$6.30M | +0.87% |
| 2016 | $726.27M | +$27.26M | +3.90% |
